Acesan

Package Leaflet: Information for the User

ACESAN, 75 mg, tablets

Acetylsalicylic acid

Read the package leaflet carefully before taking the medicine, as it contains important information for the patient.

This medicine should always be taken exactly as described in this package leaflet for the patient or as directed by a doctor or pharmacist.

• Keep this package leaflet, you may need to read it again.
• If you need advice or additional information, consult a pharmacist.
• If the patient experiences any side effects, including any possible side effects not listed in this package leaflet, they should inform their doctor or pharmacist. See section 4.
• If there is no improvement or the patient feels worse, they should contact their doctor.

Table of Contents of the Package Leaflet

• 1. What is ACESAN and what is it used for
• 2. Important information before taking ACESAN
• 3. How to take ACESAN
• 4. Possible side effects
• 5. How to store ACESAN
• 6. Contents of the package and other information

1. What is ACESAN and what is it used for

The active substance of ACESAN is acetylsalicylic acid, which inhibits the ability of blood platelets to aggregate and form blood clots. Acetylsalicylic acid belongs to the group of nonsteroidal anti-inflammatory drugs (NSAIDs). Its action is based on inhibiting the activity of the cyclooxygenase enzyme (COX), necessary for the synthesis of thromboxane A2 (TXA2), the main factor causing platelet aggregation.

Indications for use:

• Prevention of myocardial infarction in patients with multiple risk factors
• Prevention of thromboembolic complications after vascular interventions (aortocoronary bypass - CABG)
• Prevention of stroke
• In angina pectoris
• Prevention of thromboembolic complications after a recent myocardial infarction

2. Important information before taking ACESAN

When not to take ACESAN:

• if the patient is allergic to the active substance - acetylsalicylic acid, other salicylates, or any of the other ingredients of this medicine (listed in section 6),
• in patients with bleeding disorders,
• in patients with active gastric and (or) duodenal ulcers,
• in patients with severe liver failure,
• in patients with severe kidney failure,
• in patients with severe heart failure,
• in patients who have had asthma attacks in the past, caused by the administration of salicylates or substances with similar effects, especially nonsteroidal anti-inflammatory drugs,
• concomitantly with methotrexate in doses of 15 mg per week or higher,
• if the patient is in the last three months of pregnancy, doses higher than 100 mg per day should not be taken (see "Pregnancy and breastfeeding"),
• in children under 12 years of age with viral infections, such as flu or chickenpox, due to the risk of developing Reye's syndrome - a rare but serious disease that causes liver and brain damage.

Warnings and precautions

Before starting treatment with ACESAN, the patient should discuss it with their doctor or pharmacist. Acetylsalicylic acid should be used with caution:

• in the first and second trimester of pregnancy,
• during breastfeeding,
• in case of hypersensitivity to nonsteroidal anti-inflammatory and anti-rheumatic drugs or other allergenic substances,
• during concomitant use of anticoagulant drugs,
• in patients with impaired renal function,
• in patients with impaired liver function,
• in patients who have had gastric and (or) duodenal ulcers or gastrointestinal bleeding in the past,
• in patients with glucose-6-phosphate dehydrogenase deficiency,
• before planned surgery, due to the risk of bleeding.

ACESAN should not be used as a pain reliever or antipyretic. Acetylsalicylic acid may cause bronchospasm and trigger asthma attacks or other hypersensitivity reactions. Patients with asthma, chronic respiratory diseases, hay fever with nasal polyps, and those who experience allergic reactions (e.g., skin reactions, itching, hives) to other substances are particularly at risk.

Patients undergoing surgical procedures (including minor procedures, e.g., tooth extraction) should inform their doctor about taking ACESAN. It is usually recommended to discontinue the medicine 5-7 days before the planned surgical procedure.

Acetylsalicylic acid, even in small doses, reduces the excretion of uric acid from the body. In patients with a tendency to reduced uric acid excretion, the medicine may cause gout attacks.

ACESAN and other medicines

The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. Acetylsalicylic acid:

• increases the toxic effect of methotrexate on the bone marrow. Acetylsalicylic acid should not be taken concomitantly with methotrexate in doses of 15 mg per week or higher; concomitant use of methotrexate in doses less than 15 mg per week requires special caution;
• increases the effect of anticoagulant drugs (e.g., coumarin derivatives, heparin), thrombolytic drugs (dissolving blood clots, e.g., streptokinase, urokinase), and platelet aggregation inhibitors (e.g., ticlopidine), which may increase the risk of prolonged bleeding time and bleeding;
• increases the risk of gastric and (or) duodenal ulcers and gastrointestinal bleeding when taken concomitantly with corticosteroids, other nonsteroidal anti-inflammatory drugs, including other salicylates in high doses, or if alcohol is consumed during treatment.

After discontinuing systemic corticosteroids (except for hydrocortisone used as replacement therapy in Addison's disease), the risk of salicylate overdose increases;

• increases the risk of gastrointestinal bleeding when taken concomitantly with antidepressant drugs from the group of selective serotonin reuptake inhibitors (e.g., sertraline, paroxetine);
• increases the effect of digoxin, as it increases its serum concentration;
• increases the effect of antidiabetic drugs, e.g., insulin, sulfonylurea derivatives;
• increases the toxic effect of valproic acid, which in turn increases the anti-aggregatory effect of acetylsalicylic acid.

Acetylsalicylic acid reduces the effect of:

• anti-gout drugs used to treat gout, which increase the excretion of uric acid from the body (e.g., benzbromarone, probenecid), which may worsen the symptoms of gout;
• diuretic drugs;
• some antihypertensive drugs (from the group of so-called angiotensin-converting enzyme inhibitors, e.g., captopril, enalapril).

Concomitant use of ibuprofen may weaken the cardioprotective effect of acetylsalicylic acid. Concomitant use of metamizole with acetylsalicylic acid may reduce the inhibitory effect of acetylsalicylic acid on platelet aggregation. Therefore, metamizole should be used with caution in patients taking acetylsalicylic acid in low doses for protective effects on the cardiovascular system.

ACESAN can be taken concomitantly with the above-mentioned medicines only after consulting a doctor (except for methotrexate in doses of 15 mg per week or higher, when taking ACESAN is contraindicated).

ACESAN with food and drink

The medicine should be taken during a meal, with a large amount of fluid.

Pregnancy and breastfeeding

If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.

Pregnancy

If the patient continues or starts treatment with ACESAN during pregnancy in accordance with the doctor's recommendations, they should take ACESAN as directed by the doctor and not take a dose higher than recommended.

Pregnancy - last trimester

ACESAN should not be taken in a dose higher than 100 mg per day during the last 3 months of pregnancy, as it may harm the unborn child or cause complications during delivery.

Taking ACESAN may cause kidney and heart problems in the unborn child. This may affect the patient's and child's tendency to bleed and may cause delayed or prolonged labor.

If the patient takes ACESAN in low doses (up to 100 mg per day), close obstetric monitoring is necessary, as directed by the doctor.

Pregnancy - first and second trimester

ACESAN should not be taken during the first 6 months of pregnancy, unless it is absolutely necessary and has been recommended by a doctor. If the patient requires treatment during this period or is trying to conceive, they should take the lowest possible dose for the shortest possible time.

If ACESAN is taken for a longer period than a few days from the 20th week of pregnancy, it may cause kidney problems in the unborn child, leading to a decrease in the amount of amniotic fluid surrounding the fetus (oligohydramnios) or narrowing of the blood vessel (ductus arteriosus) in the child's heart.

If treatment is necessary for a longer period, the doctor may recommend additional monitoring.

Breastfeeding

Acetylsalicylic acid passes into breast milk in small amounts. Before taking the medicine, the patient should consult their doctor.

Driving and using machines

The medicine has no effect on the ability to drive vehicles or operate machines.

ACESAN contains carmoisine

Due to the presence of carmoisine, the medicine may cause allergic reactions.

ACESAN contains sodium

The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".

3. How to take ACESAN

This medicine should always be taken exactly as described in this package leaflet for the patient or as directed by a doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist.

The immediate packaging has symbols of the days of the week. They will help the patient check if the tablet intended for a given day has already been taken.

The doctor decides on the dose of ACESAN based on the patient's medical history. Usually, one tablet is taken once a day.

The tablets should be taken orally, preferably during a meal, with a large amount of fluid.

Taking a higher dose of ACESAN than recommended

In case of taking a higher dose of ACESAN than recommended, the patient should immediately consult their doctor or pharmacist, and in case of severe poisoning, the patient should be taken to the hospital immediately.

The first symptoms of poisoning are: dizziness, tinnitus, hearing loss, excessive sweating, nausea and vomiting, headache, confusion (disorders of consciousness with disorientation, thinking and speech disorders, delusions, hallucinations, anxiety, and psychomotor agitation), rapid breathing, deep breathing, and blurred vision, fainting.

In case of severe poisoning, the following may occur: high fever, disorders of heart and blood vessel function (from irregular rhythm, low blood pressure to cardiac arrest), fluid and electrolyte loss (from dehydration, oliguria - reduced urine output to less than 400-500 mL per day in adults - to kidney failure), increased or decreased blood glucose levels (especially in children), ketoacidosis (increased ketone levels in the blood), gastrointestinal bleeding, coagulation disorders, neurological disorders manifesting as lethargy, confusion, and up to coma and convulsions.

Missing a dose of ACESAN

In case of missing a dose of ACESAN, the patient should take the next dose at the usual time.

The patient should not take a double dose to make up for the missed dose.

In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.

4. Possible side effects

Like all medicines, ACESAN can cause side effects, although not everybody gets them.

The patient should stop taking ACESAN and contact their doctor immediately if they experience the first symptoms of hypersensitivity (e.g., facial, lip, tongue, or throat swelling, causing difficulty breathing or swallowing) or if bleeding occurs, e.g., gastrointestinal bleeding (symptoms: black stools) or hemorrhages.

The doctor will then assess the severity of the symptoms and decide on further action.

After taking acetylsalicylic acid, the following have been reported:

Frequently (in 1 to 10 out of 100 patients):

• symptoms of dyspepsia (heartburn, nausea, vomiting) and abdominal pain.

Rarely (in 1 to 10 out of 10,000 patients):

• inflammatory conditions of the stomach and intestines, gastric and (or) duodenal ulcers, very rarely leading to bleeding and perforation;
• transient liver function disorders (increased aminotransferase activity).

Rarely or very rarely:

• serious bleeding, such as gastrointestinal bleeding (symptoms: black stools), cerebral hemorrhage (especially in patients with uncontrolled hypertension and (or) during concomitant administration of drugs that inhibit bleeding). Bleeding may lead to acute or chronic anemia due to blood loss and (or) iron deficiency anemia (symptoms: weakness, pallor).

Very rarely (less than 1 in 10,000 patients):

• severe allergic reactions, including anaphylactic shock (symptoms: facial, eyelid, tongue, and throat swelling, significant decrease in blood pressure, and disorders of heart rhythm and breathing);
• kidney function disorders;
• decreased blood glucose levels.

Additionally, the following have been reported:

• dizziness and tinnitus (symptoms of overdose);
• hypersensitivity reactions: rash, urticaria, edema, itching, heart and respiratory disorders (including asthma);
• increased risk of bleeding, prolonged bleeding time, prolonged prothrombin time, decreased platelet count;
• peroperative bleeding, hematomas, bleeding (from the nose, genitourinary tract, gums).

When using nonsteroidal anti-inflammatory drugs, edema, hypertension, and heart failure have been reported as side effects.

Reporting side effects

If the patient experiences any side effects, including any side effects not listed in this package leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products

Al. Jerozolimskie 181C

02-222 Warsaw

Tel.: +48 22 49 21 301

Fax: +48 22 49 21 309

Website: https://smz.ezdrowie.gov.pl

Side effects can also be reported to the marketing authorization holder.

By reporting side effects, more information can be collected on the safety of the medicine.

5. How to store ACESAN

The medicine should be stored out of sight and reach of children.

Store in a temperature below 25°C.

Store in the original packaging to protect from moisture.

Do not use ACESAN after the expiry date stated on the packaging. The expiry date refers to the last day of the month.

Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the package and other information

What ACESAN contains

• The active substance of ACESAN is acetylsalicylic acid. One tablet contains 75 mg of acetylsalicylic acid.
• The excipients are: microcrystalline cellulose, sodium carboxymethylcellulose (type A), stearic acid, carmoisine, lake (E 124).

What ACESAN looks like and contents of the package

ACESAN is a pink, round, biconvex tablet with a smooth surface.

Packaging: PVC/PCTFE/Aluminum blisters in a cardboard box

Package size: 63 tablets or 200 tablets

Marketing authorization holder and manufacturer

Marketing authorization holder

SUN-FARM Sp. z o.o.

ul. Dolna 21

05-092 Łomianki

tel. +48 22 350 66 69

Manufacturer

mibe GmbH Arzneimittel

Münchener Straße 15

06796 Brehna

Germany

Date of last revision of the package leaflet: